Parkinson's drug shows promise for diabetic eye disease
NCT ID NCT07444892
First seen Mar 11, 2026 · Last updated May 20, 2026 · Updated 16 times
Summary
This study tested whether levodopa, a drug used for Parkinson's disease, can improve electrical signals in the retina of people with diabetes who have early signs of eye damage. 230 adults with diabetes took part to find the best dose and understand how the drug works. The goal is to see if levodopa can slow or prevent vision loss from diabetic retinopathy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlanta VA Medical Center
Decatur, Georgia, 30033, United States
Conditions
Explore the condition pages connected to this study.